PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+10.64%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.37B
AUM Growth
+$2.37B
(-9.4%)
Cap. Flow
-$299M
Cap. Flow
% of AUM
-12.64%
Top 10 Holdings %
Top 10 Hldgs %
36.09%
Holding
95
New
14
Increased
16
Reduced
24
Closed
14
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$30.4M |
| 2 |
Agilent Technologies
A
|
$27.5M |
| 3 |
Elevance Health
ELV
|
$21.2M |
| 4 |
Arcellx
ACLX
|
$19.1M |
| 5 |
Universal Health Services
UHS
|
$17.5M |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$83.4M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$76.2M |
| 3 |
Axsome Therapeutics
AXSM
|
$43.7M |
| 4 |
Veeva Systems
VEEV
|
$33.4M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$26.3M |
Sector Composition
| 1 | Healthcare | 95.68% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $124M | 4.45% | 1,091,840 | – | – |
|
2
Cytokinetics
CYTK
$4.23B
| $110M | 3.94% | 2,399,545 -65,471 | -3% | -$3M |
|
3
Eli Lilly
LLY
$657B
| $109M | 3.91% | 298,643 | – | – |
|
4
Centene
CNC
$14.3B
| $91.2M | 3.27% | 1,112,480 | – | – |
|
5
Humana
HUM
$36.5B
| $85.1M | 3.05% | 166,066 | – | – |
|
|
6
Axsome Therapeutics
AXSM
$6.05B
| $84.3M | 3.02% | 1,092,831 -566,902 | -34% | -$43.7M |
|
7
Penumbra
PEN
$10.6B
| $80.1M | 2.87% | 360,030 | – | – |
|
8
UnitedHealth
UNH
$281B
| $61.5M | 2.2% | 116,067 +4,513 | +4% | +$2.39M |
|
9
Arcus Biosciences
RCUS
$1.13B
| $55.9M | 2% | 2,703,287 -679,946 | -20% | -$14.1M |
|
10
AbbVie
ABBV
$372B
| $53.2M | 1.91% | 329,344 +12,181 | +4% | +$1.97M |
|
11
Prothena Corp
PRTA
$441M
| $52.7M | 1.89% | 875,464 +35,226 | +4% | +$2.12M |
|
12
uniQure
QURE
$896M
| $52.2M | 1.87% | 2,302,314 -90,997 | -4% | -$2.06M |
|
13
Cardinal Health
CAH
$35.5B
| $49.2M | 1.76% | 639,783 | – | – |
|
14
Molina Healthcare
MOH
$9.8B
| $47.5M | 1.7% | 143,779 | – | – |
|
15
IQVIA
IQV
$32.4B
| $46.9M | 1.68% | 229,081 | – | – |
|
16
Cigna
CI
$80.3B
| $46.8M | 1.68% | 141,300 | – | – |
|
17
Danaher
DHR
$147B
| $46.6M | 1.67% | 175,690 | – | – |
|
18
iRhythm Technologies
IRTC
$5.46B
| $46.2M | 1.66% | 493,721 | – | – |
|
19
Syndax Pharmaceuticals
SNDX
$1.41B
| $46.2M | 1.65% | 1,814,634 +525,561 | +41% | +$13.4M |
|
20
Biogen
BIIB
$19.4B
| $43.1M | 1.54% | 155,659 +16,333 | +12% | +$4.52M |
|
21
Merck
MRK
$210B
| $40.8M | 1.46% | 367,634 +7,114 | +2% | +$789K |
|
22
Dynavax Technologies
DVAX
$1.19B
| $40.5M | 1.45% | 3,805,370 | – | – |
|
23
McKesson
MCK
$85.4B
| $39.7M | 1.42% | 105,811 | – | – |
|
24
argenx
ARGX
$43.6B
| $39.7M | 1.42% | 104,732 | – | – |
|
25
Edwards Lifesciences
EW
$47.8B
| $39.5M | 1.42% | 530,030 +49,774 | +10% | +$3.71M |
|